Ipamorelin is described in the research literature as a selective agonist of the ghrelin receptor (also called the growth-hormone-secretagogue receptor)
Every previous GLP-1 medication, including semaglutide and tirzepatide, shows weight loss plateaus by 60 to 72 weeks
Activation of nuclear factor-B (NF-B) results in downstream pro-inflammatory cytokine release, such as tumor necrosis factor- (TNF-), interleukin (IL)-6, and IL-1, which amplify ROS-induced myocardial stress further promoting adverse remodeling, fibrosis, and myocardial dysfunction (Brasier, 2010
Research published in endocrinology journals notes that untreated or uncontrolled hyperthyroidism can worsen GLP-1 side effects including nausea and cardiovascular stress
However, according to reports from happy customers, you can expect to see weight loss results from Semaglutide within a few weeks